Table 5.

Associations Between CKD in Subjects with MAFLD Not Complicated with DM

	p-value	Odds Ratio (95% CI)
Age	0.002*	1.02 (1.01~1.04)
Hypertension	<0.001	2.01 (1.54~2.86)
Hyperuricemia	<0.001*	2.25 (1.30~3.07)
ALP	0.021*	1.01 (1.00, 1.01)
FIB-4 Score	0.060	1.00 (0.77~1.29)
NFS Score	0.494	1.05 (0.91~1.21)

Note: *A significant difference between groups.

Abbreviations: MAFLD, metabolic associated fatty liver disease; ALP, alkaline phosphatase; FIB-4, fibrosis-4; NFS, NAFLD fibrosis score.